Does the prevention of brain ageing constitute anti-ageing medicine? Outline of a new space of representation for Alzheimer's Disease

Journal of Aging Studies

Volumn 22, Issue 4, 2008, Pages 356-365

  Moreira, Tiago ^a   Bond, John ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55349118108     PISSN: 08904065     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaging.2008.05.008     Document Type: Article

References (53)

1. Alzheimer Research Forum (2008). http://www.alzforum.org/res/adh/hyp/default.asp accessed 16/01/08
2. Armstrong D. The rise of surveillance medicine. Sociology of Health and Illness 17 3 (1995) 393-404
3. Ballenger J.F. Self, Senility, and Alzheimer's Disease in Modern America: A History (2006), Johns Hopkins University Press, Baltimore
4. Bamford C., Lamont S., Eccles M., Robinson L., May C., and Bond J. Disclosing a diagnosis of dementia: a systematic review. International Journal of Geriatric Psychiatry 19 (2004) 151-169
5. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. The Lancet 368 9533 (2006) 387-403
6. Brayne C., and Calloway P. Is Alzheimer's Disease distinct from normal ageing?. The Lancet 332 8609 (1988) 514-515
7. Brayne C., and Calloway P. Normal ageing, impaired cognitive function, and senile dementia of the Alzheimers Type - a Continuum. Lancet 1 8597 (1988) 1265-1267
8. Breteler M.M.B., van Swieten J.C., Bots M.L., Grobbee D.E., Claus J.J., van den Hout J.H.W., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 44 (1994) 1246-1252
9. Brody J.A. An epidemiologist views senile dementia - facts and fragments. American Journal of Epidemiology 115(2) (1982) 155-162
10. Brown N., and Michael M. A sociology of expectations: Retrospecting prospects and prospecting retrospects. Technology Analysis & Strategic Management 15 1 (2003) 3-18
11. Clarke A.E., Mamo L., Fishman J.R., Shim J.K., and Fosket J.R. Biomedicalization: technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review 68 (2003, April) 161-194
12. Conrad P. The Shifting engines of medicalization. Journal of Health and Social Behavior 46 (2005) 3-14
13. Corner L., and Bond J. Being at risk of dementia: fears and anxieties of older adults. Journal of Aging Studies 18 (2004) 143-155
14. de Grey A. 1000-year lifespans are closer than they seem: A reply to Kirkwood, SAGE KE Bulletin Board (2005). http://sageke.sciencemag.org/community/forum/short/sageke_el_324.dtl
15. de Grey A. Resistance to debate on how to postpone ageing is delaying progress and costing lives'. EMBO Reports 6 (2005) S49-S53
16. Fox P. From senility to Alzheimer's disease: The rise of the Alzheimer's disease movement. The Milbank Quarterly 67 1 (1989) 58-102
17. Fratiglioni L., Launer L.J., Andersen K., Breteler M.M., Copeland J.R.M., Dartigues J.-F., et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 54 (2000) S10-S15
18. Gaudilliere J.-P. Inventer la biomedicine (2002), La Decouverte, Paris
19. Gilleard C., and Higgs P. Cultures of Ageing: Self, Citizen, and the Body (2000), Prentice-Hall, New York
20. Glaser B., and Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research (1967), Aldine Publishing Co, Chicago
21. Gubrium J. Oldtimers and Alzheimer's: The descriptive organization of senility (1986), JAI Press, London
22. Hardy J. A hundred years of Alzheimer's disease research. Neuron 52 1 (2006) 3-13
23. Hayflick L. Biological aspects of aging. In: Preston S. (Ed). Biological and social aspects of mortality and the length of life (1982), International Union for the Scientific Study of Population, Liege 223-258
24. Holstein M. Aging, culture and the framing of Alzheimer's disease. In: Whitehouse P.J., Maurer K., and Ballenger J. (Eds). Concepts of Alzheimer's Disease (2000), The Johns Hopkins University Press, Baltimore 158-180
25. House of Lords. Ageing: Scientific Aspects (2005), HM Office, London
26. In: Jasanoff S. (Ed). States of Knowledge (2004), Routledge, London
27. Kachaturian Z. Diagnosis of Alzheimer's disease: Two decades of progress. Alzheimer's & Dementia 1 (2005) 93-98
28. Khachaturian Z.S. A chapter in the development of Alzheimer's disease research: A case study of public policies on the development and funding of research programs. Alzheimer's and Dementia 3 3 (2007) 243-258
29. Kirkwood T. Time of our lives. EMBO Reports 6 (2005) S4-S8
30. Kirkwood T. 'Science can boost your chance of reaching a healthy old age, but don't hold your breath for immortality. Nature 436 (2005) 915-916
31. Latour B. Science in Action (1987), Harvard University Press, Cambridge MA
32. Latour B. Politics of Nature: How to bring the sciences into democracy (2004), Harvard University Press, Cambridge MA
33. Maurer K., and Maurer U. Alzheimer's: the life of physician and the career of a disease (2003), Columbia University Press, New York
34. Mckeown T. The Role of Medicine: Dream, mirage or nemesis? (1979), Blackwell, Oxford
35. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical-diagnosis of Alzheimers-Disease - Report of the Nincds-Adrda work group under the auspices of Department-of-Health-and-Human-Services task-force on Alzheimers-Disease. Neurology 34 7 (1984) 939-944
36. Merton R. The Sociology of Science: Theoretical and empirical investigations (1973), University of Chicago Press, Chicago
37. Meyer J.S., Rauch G., Rauch R.A., and Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiology of Aging 21 2 (2000) 161
38. Miller R.A. Extending Life: Scientific Prospects and Political Obstacles Vol. 80 (2002) 155-174
39. Moreira, T. (in press). Testing Promises:Truth and Hope in Drug Development and Evaluation in Alzheimer's Disease. In J. F. Ballenger, P. J. Whitehouse, C. Lyketsos, P. Rabins & J. H. T. Karlawish (Eds.), Do We Have a Pill for That? Interdisciplinary Perspectives on the Development, Use and Evaluation of Drugs in the Treatment of Dementia. Baltimore: Johns Hopkins University Press.
40. Moreira, T., May, C., & Bond, J. (in press). Regulatory Objectivity in Action: Mild Cognitive Impairment and the collective production of uncertainty. Social Studies of Science.
41. Moreira, T., & Palladino, P. (in press). Squaring the curve: the anatomo-politics of ageing, life and death. Body & Society.
42. Moreira T., Hughes J., Kirkwood T., May C.R., and Bond J. What explains variations in the clinical use of mild cognitive impairment (MCI) as a diagnostic category?. International Psychogeriatrics 20 4 (2008) 697-709
43. Olshansky S.J., Hayflick L., and Carnes B.A. Position statement on human aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57 8 (2002) B292-B297
44. In: Petersen R.C. (Ed). Mild Cognitve Impairment: Aging to Alzheimer's Disease (2003), Oxford University Press, New York
45. Petersen A., and Lupton D. The new public health: health and self in the age of risk (1996), Sage, London
46. Rattan S.I.S. 'Just a fellow who did his job1/4', an interview with Leonard Hayflick. Biogerontology 1 1 (2000) 79-87
47. Rothstein W.G. Public Health and the Risk Factor: a history of an uneven medical revolution (2003), University of Rochester Press, Rochester, MI
48. Strauss A. Qualitative analysis for social scientists (1987), Cambridge University Press, Cambridge
49. Strauss A., and Corbin J. Basics of Qualitative Research. Techniques and Procedures for Developing Grounded Theory (1998), Sage, Thousand Oaks CA
50. Vincent J. Old Age (2003), Routledge, London
51. Weiler P. Risk factors associated with senile dementia of the Alzheimer's type. American Journal of Preventative Medicine 2 5 (1986) 297-305
52. Whitehouse P.J., and Juengst E.T. Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics. Journal of the American Geriatrics Society 53 8 (2005) 1417-1422
53. In: Whitehouse P.J., Maurer K., and Ballenger J. (Eds). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives (2000), The Johns Hopkins University Press, Baltimore